// App-Quantinova.ai

: Inflammatory, degeneration and neuritic growth biomarkers predict cognitive decline and dementia in Parkinson’s disease

Researchers

Presenter

  • Sara Hall

Principal Investigators

  • Shorena Janelidze

  • Joana B Pereira

  • Henrik Zetterberg

  • Kaj Blennow

  • Oskar Hansson

Medical Centers

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden

  • UK Dementia Research Institute

  • Clinical Memory Research Unit, Lund University

  • Memory Clinic, Geneva University Hospitals

  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Sweden

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

  • Dementia

Biomarkers

  • Alpha-synuclein

  • Amyloid beta 42

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved